OS THERAPIES: EXPECTS TO COMPLETE EARLY MARKET ACCESS REGULATORY APPROVAL SUBMISSIONS FOR HERLYSTIC IN U.S., U.K., EUROPE AND AUSTRALIA IN Q4 2026

Reuters · 3d ago

Please log in to view news